Relationship between the prevalence of thyroid nodules and metabolic syndrome in the iodine-adequate area of Hangzhou, China: A cross-sectional and cohort study

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Yin, Junhua ^a   Wang, Changchun ^a   Shao, Qin ^a   Qu, Dihong ^a   Song, Zhenya ^a   Shan, Pengfei ^a   Zhang, Tao ^a   Xu, Jun ^a   Liang, Qin ^a   Zhang, Songzhao ^a   Huang, Jian ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IODINE; LIOTHYRONINE; THYROID ANTIBODY; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHINA; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ECHOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INSULIN BLOOD LEVEL; IODINE INTAKE; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK ASSESSMENT; SCREENING; SEX RATIO; THYROID FUNCTION; THYROID GLAND EXAMINATION; THYROID NODULE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84907406743     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/675796     Document Type: Article

References (33)

1. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., "Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer," Thyroid, vol. 19, no. 11, pp. 1167-1214, 2009.
2. M. J. Yeung and J. W. Serpell, "Management of the solitary thyroid nodule," Oncologist, vol. 13, no. 2, pp. 105-112, 2008.
3. P. Hagag, S. Strauss, and M. Weiss, "Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules," Thyroid, vol. 8, no. 11, pp. 989-995, 1998.
4. S. J. Mandel, "A 64-year-old woman with a thyroid nodule," The Journal of the AmericanMedical Association, vol. 292, no. 21, pp. 2632-2642, 2004.
5. L. Hegedüs, "Clinical practice. The thyroid nodule," The New England Journal of Medicine, vol. 351, no. 17, pp. 1764-1771, 2004.
6. M. Hashemipour, M. Amini, A. Aminorroaya et al., "High prevalence of goiter in an iodine replete area: do thyroid auto-antibodies play a role?" Asia Pacific Journal of Clinical Nutrition, vol. 16, no. 3, pp. 403-410, 2007.
7. W. Teng, Z. Shan, X. Teng et al., "Effect of iodine intake on thyroid diseases in China," New England Journal of Medicine, vol. 354, no. 26, pp. 2783-2793, 2006.
8. F. Aghini-Lombardi, L. Antonangeli, E. Martino et al., "The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey," Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 2, pp. 561-566, 1999.
9. W. Buchinger, O. Lorenz-Wawschinek, G. Semlitsch et al., "Thyrotropin and thyroglobulin as an index of optimal iodine intake: correlation with iodine excretion of 39,913 euthyroid patients," Thyroid, vol. 7, no. 4, pp. 593-597, 1997.
10. A. Roos, S. J. Bakker, T. P. Links et al., "Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects," The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 491-496, 2007.
11. S. B. Park, H. C. Choi, and N. S. Joo, "The relation of thyroid function to components of the metabolic syndrome in Korean men and women," Journal of KoreanMedical Science, vol. 26, no. 4, pp. 540-545, 2011.
12. C. Pirich, M. Müllner, and H. Sinzinger, "Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants," Journal of Clinical Epidemiology, vol. 53, no. 6, pp. 623-629, 2000.
13. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, "The metabolic syndrome," The Lancet, vol. 365, no. 9468, pp. 1415-1428, 2005.
14. R. Sari, M. K. Balci, H. Altunbas, and U. Karayalcin, "The effect of body weight and weight loss on thyroid volume and function in obese women," Clinical Endocrinology, vol. 59, no. 2, pp. 258-262, 2003.
15. C. Anil, A. Akkurt, S. Ayturk, A. Kut, and A. Gursoy, "Impaired glucosemetabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area," Metabolism, vol. 62, no. 7, pp. 970-975, 2013.
16. J. Deng, W. M. Xu, X. X. Zhu et al., "The iodine status in Hangzhou, Zhejiang province 2010," Zhonghua Liu Xing Bing Xue Za Zhi, vol. 32, no. 10, pp. 1009-1013, 2010.
17. World Health Organization/UNICEF/International Council for the Control of Iodine Deficiency Disorders, "Assessment of iodine deficiency disorders and monitoring their elimination. A guide for programme managers (3rd edition)," Geneva, Switzerland, WHO, 2007.
18. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, "Metabolic syndrome: a new world-wide definition: a consensus statement from the International Diabetes Federation," Diabetic Medicine, vol. 23, no. 5, pp. 469-480, 2006.
19. P. Caturegli, A. de Remigis, and N. R. Rose, "Hashimoto thyroiditis: clinical and diagnostic criteria," Autoimmunity Reviews, vol. 13, no. 4-5, pp. 391-397, 2014.
20. J. Rezzonico, M. Rezzonico, E. Pusiol, F. Pitoia, and H. Niepomniszcze, "Introducing the thyroid gland as another victimof the insulin resistance syndrome," Thyroid, vol. 18, no. 4, pp. 461-464, 2008.
21. Expert Panel on Detection; Evaluation; and Treatment of High Blood Cholesterol in Adults, "Executive Summary of The Third Report of The National Cholesterol Education Program(NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)," JAMA, vol. 285, no. 19, pp. 2486-2497, 2001.
22. A. Van Keymeulen, J. E. Dumont, and P. P. Roger, "TSH induces insulin receptors that mediate insulin costimulation of growth in normal human thyroid cells," Biochemical and Biophysical Research Communications, vol. 279, no. 1, pp. 202-207, 2000.
23. R. J. Huggett, J. Burns, A. F. Mackintosh, and D. A. S. G. Mary, "Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension," Hypertension, vol. 44, no. 6, pp. 847-852, 2004.
24. L. Landsberg, "Insulin resistance and the metabolic syndrome," Diabetologia, vol. 48, no. 7, pp. 1244-1246, 2005.
25. G. Grassi, R. Dell'Oro, F. Quarti-Trevano et al., "Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome," Diabetologia, vol. 48, no. 7, pp. 1359-1365, 2005.
26. G. Grassi, R. Dell'Oro, A. Facchini, F. Q. Trevano, G. B. Bolla, and G. Mancia, "Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives," Journal of Hypertension, vol. 22, no. 12, pp. 2363-2369, 2004.
27. G. de Pergola, A. Ciampolillo, S. Paolotti, P. Trerotoli, and R. Giorgino, "Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women," Clinical Endocrinology, vol. 67, no. 2, pp. 265-269, 2007.
28. W. Jiang, T.Miyamoto, T.Kakizawa et al., "Expression of thyroid hormone receptor α in 3T3-L1 adipocytes; triiodothyronine increases the expression of lipogenic enzyme and triglyceride accumulation," Journal of Endocrinology, vol. 182, no. 2, pp. 295-302, 2004.
29. F. Akin, M. Bastemir, E. Alkis, and B. Kaptanoglu, "Associations between sex hormone binding globulin and metabolic syndrome parameters in premenopausal obese women," Indian Journal of Medical Sciences, vol. 62, no. 10, pp. 407-415, 2008.
30. F. Akin, M. Bastemir, E. Alkis et al., "SHBG levels correlate with insulin resistance in postmenopausal women," European Journal of Internal Medicine, vol. 20, no. 2, pp. 162-167, 2009.
31. S. K. Kakkos, C. D. Scopa, A. K. Chalmoukis et al., "Relative risk of cancer in sonographically detected thyroid nodules with calcification," Journal of Clinical Ultrasound, vol. 28, no. 7, pp. 347-352, 2000.
32. H. W. Kang, J. H. No, J. H. Chung et al., "Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas," Thyroid, vol. 14, no. 1, pp. 29-33, 2004.
33. S. Ayturk, A. Gursoy, A. Kut, C. Anil, A. Nar, and N. B. Tutuncu, "Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area," European Journal of Endocrinology, vol. 161, no. 4, pp. 599-605, 2009.